Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Monneret

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Annales Pharmaceutiques Francaises|June 24, 2010
[Reinventing thalidomide under high supervision]C Monneret
Annales Pharmaceutiques Francaises|March 30, 2013
[Four new drugs on the market: abiraterone, belatacept, vandetanib and fidaxomycine]C Monneret
Annales Pharmaceutiques Francaises|May 4, 2010
[Prohibit or not bisphenol-A?]C Monneret
Annales Pharmaceutiques Francaises|November 26, 2011
Platinum anticancer drugs. From serendipity to rational designC Monneret
Annales Pharmaceutiques Francaises|July 20, 2010
[Current impact of natural products in the discovery of anticancer drugs]C Monneret
Annales Pharmaceutiques Francaises|February 15, 2007
[Glycochemistry and therapeutics. Introduction]C Monneret
Annales Pharmaceutiques Francaises|July 7, 2014
[Two news drugs (ivacaftor & bedaquiline), one biomarker (florbetapir) and a re-positioned drug (propranolol) on the market]C Monneret
European Journal of Medicinal Chemistry|August 30, 2001
Recent developments in the field of antitumour anthracyclinesC Monneret
Annales Pharmaceutiques Francaises|July 31, 1999
[Glycochemistry: biological implications and therapeutic applications. Convened October 21, 1998 by the National Academy of Pharmacy]C Monneret
Annales Pharmaceutiques Francaises|March 21, 2009
[Melamine in question]C Monneret
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Annales Pharmaceutiques Francaises|June 24, 2010
[Reinventing thalidomide under high supervision]C Monneret
Annales Pharmaceutiques Francaises|March 30, 2013
[Four new drugs on the market: abiraterone, belatacept, vandetanib and fidaxomycine]C Monneret
Annales Pharmaceutiques Francaises|May 4, 2010
[Prohibit or not bisphenol-A?]C Monneret
Annales Pharmaceutiques Francaises|November 26, 2011
Platinum anticancer drugs. From serendipity to rational designC Monneret
Annales Pharmaceutiques Francaises|July 20, 2010
[Current impact of natural products in the discovery of anticancer drugs]C Monneret
Annales Pharmaceutiques Francaises|February 15, 2007
[Glycochemistry and therapeutics. Introduction]C Monneret
Annales Pharmaceutiques Francaises|July 7, 2014
[Two news drugs (ivacaftor & bedaquiline), one biomarker (florbetapir) and a re-positioned drug (propranolol) on the market]C Monneret
European Journal of Medicinal Chemistry|August 30, 2001
Recent developments in the field of antitumour anthracyclinesC Monneret
Annales Pharmaceutiques Francaises|July 31, 1999
[Glycochemistry: biological implications and therapeutic applications. Convened October 21, 1998 by the National Academy of Pharmacy]C Monneret
Annales Pharmaceutiques Francaises|March 21, 2009
[Melamine in question]C Monneret
Pageof 6